Morpho (MORPHO) is currently priced at $1.17, reflecting a slight decline of 1.19% over the last 24 hours. The asset's daily trading range has been narrow, with a high of $1.19 and a low of $1.17, indicating low volatility in the short term.

The trading volume stands at approximately 6.68 million, which constitutes 1.05% of the market cap, suggesting a moderate level of trading activity relative to its overall market size. Moving averages are indicating bearish trends, with the 8 SMA at $1.18 showing a decrease of 0.62%, while the 55 SMA is down by 1.07%, highlighting a consistent downward pressure on the price.

The 1-hour RSI is at 36, indicating that the asset is nearing oversold territory, while the 7-day RSI of 48 reflects a neutral position without strong momentum in either direction. Over the past week, the price has decreased by 3.65%, but it has shown some recovery over the past two weeks with a 4.96% increase, suggesting potential short-term resilience.

However, looking at the 30-day price change of -23.87%, Morpho has faced significant selling pressure recently, raising concerns about its medium-term stability. The all-time high remains at $4.17, achieved in January 2025, which highlights the substantial distance from current levels and the potential for long-term growth if bullish conditions return.

In conclusion, the overall technical indicators suggest that Morpho is currently in a bearish trend with limited short-term upside potential. Given the combination of recent price declines, lack of strong buying momentum, and the current RSI readings, I recommend a Hold rating, advising investors to monitor for signs of stabilization before considering new positions.